Literature DB >> 2515788

Purification and properties of human erythrocyte arginase.

M Ikemoto1, M Tabata, T Murachi, M Totani.   

Abstract

An efficient method for purification of human erythrocyte arginase was developed. This method included two new procedures, hydrophobic chromatography and immunoaffinity chromatography, and yielded 0.7 mg of homogeneous arginase protein from 2.1 L of haemolysate. The molecular weight of native arginase was estimated to be 105,000 by gel filtration on a Sephadex G-150 column, and that of its subunit 35,000 by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate. This indicates that the native enzyme is composed of three homologous subunits. Amino acid composition of human erythrocyte arginase was found to be very similar to that of liver arginase of several other mammals. After dialysis against distilled water, the purified arginase still retained its enzymatic activity which was decreased by EDTA and reversibly restored by Mn(II) ion. A specific polyclonal antibody for use in an immunoassay was also produced. This antibody revealed one single band on immunoelectrophoretic analysis of the acetone powder extract, suggesting absence of arginase isoenzymes in human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515788     DOI: 10.1177/000456328902600616

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1.  Expression of human liver arginase in Escherichia coli. Purification and properties of the product.

Authors:  M Ikemoto; M Tabata; T Miyake; T Kono; M Mori; M Totani; T Murachi
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

2.  A bioengineered arginine-depleting enzyme as a long-lasting therapeutic agent against cancer.

Authors:  Sai-Fung Chung; Chi-Fai Kim; Suet-Ying Tam; Man-Chung Choi; Pui-Kin So; Kwok-Yin Wong; Yun-Chung Leung; Wai-Hung Lo
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-06       Impact factor: 4.813

3.  Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC).

Authors:  Sam-Mui Tsui; Wai-Man Lam; Tin-Lun Lam; Hiu-Chi Chong; Pui-Kin So; Sui-Yi Kwok; Simon Arnold; Paul Ning-Man Cheng; Denys N Wheatley; Wai-Hung Lo; Yun-Chung Leung
Journal:  Cancer Cell Int       Date:  2009-04-17       Impact factor: 5.722

4.  L-Arginine Depletion Improves Spinal Cord Injury via Immunomodulation and Nitric Oxide Reduction.

Authors:  Céline Erens; Jana Van Broeckhoven; Cindy Hoeks; Gernot Schabbauer; Paul N Cheng; Li Chen; Niels Hellings; Bieke Broux; Stefanie Lemmens; Sven Hendrix
Journal:  Biomedicines       Date:  2022-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.